Literature DB >> 26739693

Neurodegeneration with Brain Iron Accumulation.

Susanne A Schneider1,2.   

Abstract

Syndromes with neurodegeneration with brain iron accumulation (NBIA) are a group of neurodegenerative disorders characterized by abnormalities in brain iron metabolism with excess iron accumulation in the globus pallidus and to a lesser degree in the substantia nigra and sometimes adjacent areas. They clinically present as neurodegenerative diseases with progressive hypo- and/or hyperkinetic movement disorders and a variable degree of pyramidal, cerebellar, peripheral nerve, autonomic, cognitive and psychiatric involvement, and visual dysfunction. Several causative genes underlying NBIA have been identified which explain about 65% of cases. Pathophysiologically, many of the NBIA syndromes map into related biochemical pathways and gene networks including mitochondrial pathways, lipid metabolism, and autophagy. Treatment for NBIA disorders remains symptomatic but a placebo-controlled double-blind study is underway. Rapid developments prompted the review of this interesting field.

Entities:  

Keywords:  Basal ganglia; Dystonia; Hallervorden-Spatz; Iron accumulation; PKAN; Pallidum

Mesh:

Substances:

Year:  2016        PMID: 26739693     DOI: 10.1007/s11910-015-0608-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  97 in total

1.  Treatment of a dystonic storm with pallidal stimulation in a patient with PANK2 mutation.

Authors:  Francisco Grandas; Carlos Fernandez-Carballal; Juan Guzman-de-Villoria; Israel Ampuero
Journal:  Mov Disord       Date:  2011-03-21       Impact factor: 10.338

2.  Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Michael C Kruer; Coro Paisán-Ruiz; Nathalie Boddaert; Moon Y Yoon; Hiroko Hama; Allison Gregory; Alessandro Malandrini; Randall L Woltjer; Arnold Munnich; Stephanie Gobin; Brenda J Polster; Silvia Palmeri; Simon Edvardson; John Hardy; Henry Houlden; Susan J Hayflick
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

3.  Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.

Authors:  Norbert Brüggemann; Johann Hagenah; Kathrin Reetz; Alexander Schmidt; Meike Kasten; Inga Buchmann; Susanne Eckerle; Manfred Bähre; Alexander Münchau; Ana Djarmati; Joyce van der Vegt; Hartwig Siebner; Ferdinand Binkofski; Alfredo Ramirez; Maria I Behrens; Christine Klein
Journal:  Arch Neurol       Date:  2010-11

4.  Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration.

Authors:  Martin Krause; Wolfgang Fogel; Volker Tronnier; Sabine Pohle; Konstanze Hörtnagel; Ute Thyen; Jens Volkmann
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

5.  C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis.

Authors:  M Deschauer; C Gaul; C Behrmann; H Prokisch; S Zierz; T B Haack
Journal:  J Neurol       Date:  2012-05-15       Impact factor: 4.849

6.  A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuropathy.

Authors:  Rita Horvath; Elke Holinski-Feder; Vivienne C M Neeve; Angela Pyle; Helen Griffin; Deephthi Ashok; Charlotte Foley; Gavin Hudson; Bernd Rautenstrauss; Gudrun Nürnberg; Peter Nürnberg; Jörg Kortler; Birgit Neitzel; Ingelore Bässmann; Thahira Rahman; Bernard Keavney; John Loughlin; Sophie Hambleton; Benedikt Schoser; Hanns Lochmüller; Mauro Santibanez-Koref; Patrick F Chinnery
Journal:  Mov Disord       Date:  2012-04-16       Impact factor: 10.338

7.  Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.

Authors:  Jose Bras; Alain Verloes; Susanne A Schneider; Sara E Mole; Rita J Guerreiro
Journal:  Hum Mol Genet       Date:  2012-03-02       Impact factor: 6.150

8.  Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation.

Authors:  Taiji Tsunemi; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2013-12-13       Impact factor: 5.121

9.  A Novel PANK2 Mutation in a Patient with Atypical Pantothenate-Kinase-Associated Neurodegeneration Presenting with Adult-Onset Parkinsonism.

Authors:  Joo-Hyun Seo; Sook-Keun Song; Phil Hyu Lee
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

10.  Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation.

Authors:  Sabrina Dusi; Lorella Valletta; Tobias B Haack; Yugo Tsuchiya; Paola Venco; Sebastiano Pasqualato; Paola Goffrini; Marco Tigano; Nikita Demchenko; Thomas Wieland; Thomas Schwarzmayr; Tim M Strom; Federica Invernizzi; Barbara Garavaglia; Allison Gregory; Lynn Sanford; Jeffrey Hamada; Conceição Bettencourt; Henry Houlden; Luisa Chiapparini; Giovanna Zorzi; Manju A Kurian; Nardo Nardocci; Holger Prokisch; Susan Hayflick; Ivan Gout; Valeria Tiranti
Journal:  Am J Hum Genet       Date:  2013-12-19       Impact factor: 11.025

View more
  15 in total

Review 1.  Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.

Authors:  Yanwei Li; Jinying Zhao; Christian Hölscher
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

Review 2.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

3.  Is brain iron trafficking part of the physiology of the amyloid precursor protein?

Authors:  Danielle K Bailey; Daniel J Kosman
Journal:  J Biol Inorg Chem       Date:  2019-10-01       Impact factor: 3.358

4.  Biallelic inactivating variants in the GTPBP2 gene cause a neurodevelopmental disorder with severe intellectual disability.

Authors:  Aida M Bertoli-Avella; Jose M Garcia-Aznar; Oliver Brandau; Fahad Al-Hakami; Zafer Yüksel; Anett Marais; Nana-Maria Grüning; Lia Abbasi Moheb; Omid Paknia; Nahla Alshaikh; Seham Alameer; Makia J Marafi; Fahd Al-Mulla; Nouriya Al-Sannaa; Arndt Rolfs; Peter Bauer
Journal:  Eur J Hum Genet       Date:  2018-02-15       Impact factor: 4.246

5.  Iron accumulation and dysregulation in the putamen in fragile X-associated tremor/ataxia syndrome.

Authors:  Jeanelle Ariza; Hailee Rogers; Anna Hartvigsen; Melissa Snell; Michael Dill; Derek Judd; Paul Hagerman; Verónica Martínez-Cerdeño
Journal:  Mov Disord       Date:  2017-02-24       Impact factor: 10.338

6.  Neurodegeneration with brain iron accumulation: A case report.

Authors:  Daniel Nassif; João Santos Pereira; Mariana Spitz; Cláudia Capitão; Alessandra Faria
Journal:  Dement Neuropsychol       Date:  2016 Apr-Jun

7.  Late diagnosis and atypical brain imaging of Aicardi-Goutières syndrome: are we failing to diagnose Aicardi-Goutières syndrome-2?

Authors:  Leah Svingen; Mitchell Goheen; Rena Godfrey; Colleen Wahl; Eva H Baker; William A Gahl; May Christine V Malicdan; Camilo Toro
Journal:  Dev Med Child Neurol       Date:  2017-08-01       Impact factor: 5.449

8.  Japanese WDR45 de novo mutation diagnosed by exome analysis: A case report.

Authors:  Hironobu Endo; Takeshi Uenaka; Wataru Satake; Yutaka Suzuki; Hisatsugu Tachibana; Norio Chihara; Takehiro Ueda; Kenji Sekiguchi; Taniguchi-Ikeda Mariko; Hisatomo Kowa; Fumio Kanda; Tatsushi Toda
Journal:  Neurol Clin Neurosci       Date:  2017-06-29

9.  Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration.

Authors:  Paolo Santambrogio; Maddalena Ripamonti; Chiara Paolizzi; Celeste Panteghini; Miryam Carecchio; Luisa Chiapparini; Marzia Raimondi; Alicia Rubio; Ivano Di Meo; Anna Cozzi; Stefano Taverna; Giuseppe De Palma; Valeria Tiranti; Sonia Levi
Journal:  Int J Mol Sci       Date:  2020-05-22       Impact factor: 5.923

10.  Human 3D Cultures as Models for Evaluating Magnetic Nanoparticle CNS Cytotoxicity after Short- and Repeated Long-Term Exposure.

Authors:  Uliana De Simone; Marianna Roccio; Laura Gribaldo; Arsenio Spinillo; Francesca Caloni; Teresa Coccini
Journal:  Int J Mol Sci       Date:  2018-07-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.